Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
 
 

      this event, the parties will equally bear any special expenses resulting from that decision;
  (c)   Before rendering their final decision, the arbitrators will first act as friendly, disinterested parties for the purpose of helping the parties reach compromise settlements on the points in dispute; and
 
  (d)   The costs of the arbitration will be in the discretion of the arbitrators, provided, however, that no party is obliged to pay more than its own costs, the costs of the arbitrator it has nominated, and the cost of the third arbitrator.
ARTICLE 21 – ENTIRE UNDERSTANDING
  21.01   This AGREEMENT represents the entire understanding between the parties, and supersedes all other agreements, express or implied, between the parties concerning the subject matter hereof, and shall not be subject to any change or modification except by the execution of a written instrument subscribed to by the parties hereto.
     IN WITNESS WHEREOF, the parties hereto have executed this AGREEMENT on the dates set forth below.
                 
LEE G. DANTE       OREXIGEN THERAPEUTICS, INC.    
 
               
/s/ Lee G. Dante M.D.
 
      By:   /s/ John F. Crowley
 
   
        John F. Crowley    
        President and Chief Executive Officer    
 
               
Date: 6/11/04       Date: 6/10/04    

- 22 -